Drug recall · July 11, 2012
Loxapine Capsules USP recall
Why: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0371-01
- Lots / codes
Lot #s: 101696A, 110829A, 123685A, 123687A
- Quantity
- 21,572 bottles
- Company
- Watson Laboratories Inc, Corona, CA
- Distribution
- Nationwide.
- Initiated
- April 17, 2012 · Voluntary: Firm initiated
- Classified
- June 29, 2012
- Reported
- July 11, 2012
- Ended
- March 18, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Loxapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.